On May 23, 2018, we published revised versions of our Privacy Policy and User Agreements. Please read these updated terms and take some time to understand them. Your use of our services is subject to these revised terms.
Yes, I Agree.
TuesdayApr 30, 2013 1:35 pm

ZBB Energy Corp. (ZBB) Ships ZBB EnerStore to Resort in French Polynesia

ZBB Energy designs, develops, and manufactures advanced energy storage, power electronic systems, and engineered custom and semi-custom products targeted at the growing global need for distributed renewable energy, energy efficiency, power quality, and grid modernization. The company today announced it has shipped a previously reported order from Pacific Beachcomber to supply a 2,000 kilowatt ZBB EnerStore system, including 40 ZBB EnerStore modules. The order went to Pacific Beachcomber's Brando Resort, a luxury eco-resort located in French Polynesia. Some of the revenue from the sale will be recognized in the company's Q3/13, with the remainder recognized during Q1/14. The EnerStore system…

Continue Reading

TuesdayApr 30, 2013 1:10 pm

Gevo, Inc. (GEVO) Awarded 10th Patent in its Biocatalyst Portfolio

Gevo, a renewable chemicals and next-generation biofuels company, today reported that it has received a new patent from the U.S. Patent Office covering the company’s foundational methods for producing low-cost isobutanol at commercially relevant titer, productivity, and yields. The ‘374 Patent protects the company’s strategy of converting existing ethanol plants into bio-refineries to make isobutanol, a naturally occurring four-carbon alcohol. "This is a milestone achievement toward our goal of making commercial isobutanol a reality," Brett Lund, Gevo's executive vice president and general counsel stated in the press release. "This patent significantly strengthens Gevo's intellectual property position and reinforces our unmatched…

Continue Reading

TuesdayApr 30, 2013 10:55 am

GlobalWise Investments, Inc. (GWIV) CEO to Present at Taglich Brothers 10th Annual Small Cap Equity Conference

GlobalWise Investments, an Enterprise Content Management (ECM) company operating through wholly owned subsidiary Intellinetics, today reports that company president and CEO William "BJ" Santiago is scheduled to present at the Taglich Brothers 10th Annual Small Cap Equity Conference May 7, 2013, at 9 a.m. EDT. Immediately following the presentation, Santiago will participate in a Q&A session to provide additional information. Taglich Brothers’ annual small-cap conference features companies from every industry within the microcap segment of the market. The conference will take place at the New York Athletic Club, New York City. To request additional information or to register, contact Taglich…

Continue Reading

TuesdayApr 30, 2013 10:13 am

Cardium Therapeutics, Inc. (CXM) to Showcase Excellagen® in Poster Presentation at the 2013 Spring SAWC/WHS Meeting

Cardium Therapeutics, an asset-based health sciences and regenerative medicine company, is scheduled to present a poster demonstrating the clinical benefits of its lead commercial product, Excellagen®, at The Symposium on Advanced Wound Care and Wound Healing Society (SAWC/WHS) meeting to be held May 1-5, 2013, in Denver, Colorado. Authored by Steven Smith, M.D., Mohs surgeon, of Wellesley, Mass, the presentation titled "Accelerated Granulation and Healing of Problematic Post-Surgical Wounds with Formulated Collagen Gel 2.6%" will be presented by Lois Chandler, Ph.D., Cardium's vice president of Biologics Development. As an advanced regenerative wound product, Excellagen is capable of promoting rapid granulation…

Continue Reading

TuesdayApr 30, 2013 9:26 am

The Aristocrat Group Corp. (ASCC) Wins Patent Approval for New Vodka Brand – Name Debut on the Horizon

The Aristocrat Group achieved a key breakthrough this week in its trek to release a new brand of ultra-premium vodka when Luxuria Brands, Aristocrat’s brand management division, received approval from the U.S. Patent and Trademark Office for the distilled spirit’s proposed name. Luxuria Brands is now awaiting Certification of Label/Bottle Approval (COLA) from the Alcohol and Tobacco Tax and Trade Bureau (TTB) to ensure that the new spirit has been created, labeled, and marketed in compliance with federal laws and regulations. The company anticipates receiving the certification this week and will soon reveal the name of its debut vodka. “We’re…

Continue Reading

TuesdayApr 30, 2013 9:19 am

Islet Sciences, Inc. (ISLT) Announces Receipt of Japanese Patent Covering New Diabetes Medications

Biotechnology company Islet Sciences has announced the receipt of a Japanese patent for allowed claims covering new medications for diabetes. The notice of allowed claims for Patent Application No. 2008-529208 includes the use and composition for small molecules in preventing or treating pathological inflammatory or autoimmune condition – in particular, type 1 diabetes, atherosclerosis, type 2 diabetes, disorders related to visceral obesity, multiple sclerosis, inflammatory bowel disease, psoriasis, rheumatoid arthritis, and Alzheimer’s disease. The patent signifies an additional aspect to the value of Islet Sciences’ therapies, which represent a large market opportunity for the diabetic community and also for the…

Continue Reading

TuesdayApr 30, 2013 9:17 am

Echelon Corp. (ELON) Announces Partnership with ITOCHU and Mitsui for Street Lighting Control System Pilots in Japan

Echelon, the world's leading open standard energy control networking company, announced several leading Japanese cities are now piloting street lighting management systems based on technology from Echelon after witnessing the company's successful demonstration of intelligent street lighting control in the Japanese technology city of Tsukuba in 2011. The piloted systems are configured on the open ISO/IEC 14908 standard and implemented using Echelon's Power Line Communications (PLC) transceivers and segment controllers. ITOCHU Corporation, an Echelon partner, has installed the second phase in the city of Tsukuba. This project was accomplished in cooperation with Panasonic and Toshiba, major Japanese lighting device manufacturers.…

Continue Reading

TuesdayApr 30, 2013 9:13 am

Emisphere Technologies, Inc. (EMIS) and Novo Nordisk (NVO) Amend Development and License Agreement

Emisphere Technologies, a biopharm company, and Novo Nordisk A/S have amended their development and license agreement under which the companies are working to develop and commercialize oral formulations of Novo Nordisk's proprietary GLP-1 receptor agonists, which have the potential of treating Type 2 diabetes, using Emisphere's Eligen® technology. Per the amendment, Novo Nordisk will pay to Emisphere $10 million as a prepayment of development milestone payments that would have otherwise been paid to Emisphere upon the initiation of phase II and phase III testing of an oral GLP-1 product by Novo Nordisk. Novo Nordisk is currently conducting phase I trials…

Continue Reading

TuesdayApr 30, 2013 9:09 am

Rand Worldwide, Inc. (RWWI) Division Announces Release of Powerful, New Scan to BIM™ 2014 Software

Rand Worldwide, a prominent supplier of technology solutions to organizations with engineering design and information technology requirements worldwide, announced today that its IMAGINiT Technologies division has released its innovative Scan to BIM 2014 software. This new software enables streamlined workflows from intelligent 3D data from captured laser scans by utilizing the new Autodesk ReCap Point Cloud Engine. In addition to providing powerful new features, the new software package maintains complete compatibility with the Autodesk Revit 2014. "By keeping our software development in lockstep with Autodesk software rollouts, we ensure customers are able to leverage every benefit that a new release…

Continue Reading

TuesdayApr 30, 2013 8:55 am

Rainbow Coral Corp. (RBCC) Prepares for Revolution in Pharmaceutical and Insurance Industries

The rapid growth of personalized genomic medicine is poised to radically change not only the way that pharmaceutical companies develop drugs, but the way insurance companies administer healthcare plans. Acknowledging the increasing momentum, Rainbow Coral today told investors that it is forging ahead with plans for new partnerships in both genetic testing and companion diagnostics. PricewaterhouseCoopers predicts that the personalized medicine sector could grow to as much as $452 billion by 2015. One of the driving forces behind this expansion is the inefficient way in which drugs are currently produced. Because insurance companies try to avoid paying for drugs that…

Continue Reading

Market Basics

New to the micro-cap markets?Get answers to your questions about investing in Small-Cap / Micro-Cap Stocks and learn how to protect yourself.

The Basics

Newsletter Publishers

Have an up and coming newsletter and want to be included in our coverage list? Looking to get more coverage and grow subscriptions? Register for coverage.


Public Companies

Are you a Small-Cap / Micro-Cap company looking for coverage? We'd love to hear from you. Fill out our quick contact form or send us a text.

Get Covered